Upcoming earnings
Next report date
Report period
Q1 2024
EPS estimate
—
Revenue estimate
—
Key stats
About RESPONSE GENETICS INC
Response Genetics, Inc. is engaged in the research and development of clinical diagnostic tests for cancer. Its platforms include analysis of single biomarkers using the polymerase chain reaction method as well as global gene interrogation using microarray methods from paraffin or frozen tissue specimens. It also provides pharmacogenomic testing services of clinical trial specimens to pharmaceutical companies. The company was founded by David A. Smith and Kathleen Danenberg on September 23, 1999 and is headquartered in Los Angeles, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of RGDXQ is 0.000001 USD — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange RESPONSE GENETICS INC stocks are traded under the ticker RGDXQ.
RESPONSE GENETICS INC is going to release the next earnings report on May 16, 2024. Keep track of upcoming events with our Earnings Calendar.
RGDXQ stock is 0% volatile and has beta coefficient of 14.93. Check out the list of the most volatile stocks — is RESPONSE GENETICS INC there?
No, RGDXQ doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, RGDXQ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade RESPONSE GENETICS INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So RESPONSE GENETICS INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating RESPONSE GENETICS INC stock shows the sell signal. See more of RESPONSE GENETICS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.